Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition.
Oncotarget. 2017 May 25;8(41):69204-69218. doi: 10.18632/oncotarget.18213. eCollection 2017 Sep 19.
Oncotarget. 2017.
PMID: 29050198
Free PMC article.
Inhibition of Akt and other AGC kinases: A target for clinical cancer therapy?
Prêtre V, Wicki A.
Prêtre V, et al.
Semin Cancer Biol. 2018 Feb;48:70-77. doi: 10.1016/j.semcancer.2017.04.011. Epub 2017 May 1.
Semin Cancer Biol. 2018.
PMID: 28473255
Review.
Item in Clipboard
Pre-existing antihypertensive treatment predicts early increase in blood pressure during bevacizumab therapy: the prospective AVALUE cohort study.
Wicki A, Hermann F, Prêtre V, Winterhalder R, Kueng M, von Moos R, Rochlitz C, Herrmann R.
Wicki A, et al. Among authors: pretre v.
Oncol Res Treat. 2014;37(5):230-6. doi: 10.1159/000362376. Epub 2014 Apr 8.
Oncol Res Treat. 2014.
PMID: 24853781
Clinical Trial.
Item in Clipboard
Synergism of peptide receptor-targeted Auger electron radiation therapy with anti-angiogenic compounds in a mouse model of neuroendocrine tumors.
Wicki A, Wild D, Prêtre V, Mansi R, Orleth A, Reubi JC, Rochlitz C, Mamot C, Mäcke HR, Christofori G.
Wicki A, et al. Among authors: pretre v.
EJNMMI Res. 2014 Feb 16;4(1):9. doi: 10.1186/2191-219X-4-9.
EJNMMI Res. 2014.
PMID: 24528513
Free PMC article.
Item in Clipboard
First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13).
Wicki A, Brown N, Xyrafas A, Bize V, Hawle H, Berardi S, Cmiljanović N, Cmiljanović V, Stumm M, Dimitrijević S, Herrmann R, Prêtre V, Ritschard R, Tzankov A, Hess V, Childs A, Hierro C, Rodon J, Hess D, Joerger M, von Moos R, Sessa C, Kristeleit R.
Wicki A, et al. Among authors: pretre v.
Eur J Cancer. 2018 Jun;96:6-16. doi: 10.1016/j.ejca.2018.03.012. Epub 2018 Apr 13.
Eur J Cancer. 2018.
PMID: 29660598
Clinical Trial.
Item in Clipboard
Interleukin-1 (IL-1) and the inflammasome in cancer.
Pretre V, Papadopoulos D, Regard J, Pelletier M, Woo J.
Pretre V, et al.
Cytokine. 2022 May;153:155850. doi: 10.1016/j.cyto.2022.155850. Epub 2022 Mar 10.
Cytokine. 2022.
PMID: 35279620
Free article.
Review.
Item in Clipboard
EPIK-O/ENGOT-OV61: alpelisib plus olaparib vs cytotoxic chemotherapy in high-grade serous ovarian cancer (phase III study).
Konstantinopoulos PA, Gonzalez-Martin A, Cruz FM, Friedlander M, Glasspool R, Lorusso D, Marth C, Monk BJ, Kim JW, Hinson P, Ajipa O, Pretre V, Han Y, Matulonis UA.
Konstantinopoulos PA, et al. Among authors: pretre v.
Future Oncol. 2022 Oct;18(31):3481-3492. doi: 10.2217/fon-2022-0666. Epub 2022 Sep 6.
Future Oncol. 2022.
PMID: 36066851
Free article.
Item in Clipboard
As the world turns: short-term human spatial memory in egocentric and allocentric coordinates.
Banta Lavenex P, Lecci S, Prêtre V, Brandner C, Mazza C, Pasquier J, Lavenex P.
Banta Lavenex P, et al. Among authors: pretre v.
Behav Brain Res. 2011 May 16;219(1):132-41. doi: 10.1016/j.bbr.2010.12.035. Epub 2011 Jan 12.
Behav Brain Res. 2011.
PMID: 21237209
Item in Clipboard
Cite
Cite